First Trust Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

First Trust Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,496,007	Closed	-$32.1M	–	171
2026 Q1	$32.1M	Buy	+1,496,007	New	+$21.1M	1.69%	14

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

First Trust Capital Management's DAWN Position: Q2 2026 in Review

First Trust Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 1,496,007 shares — an estimated $32.1M sold.

First Trust Capital Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $32.1M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

First Trust Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
First Trust Capital Management sold 1,496,007 Day One Biopharmaceuticals shares in Q2 2026, an estimated $32.1M.
First Trust Capital Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
First Trust Capital Management's Day One Biopharmaceuticals position peaked at $32.1M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on First Trust Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.